← Back to Search

Behavioral Intervention

Community Empowerment for Mental Health (COPE Trial)

N/A
Recruiting
Led By Jennifer L Scott, PhD, LCSW
Research Sponsored by Louisiana State University and A&M College
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up t1 (pre-intervention), t2 (1 month post-intervention), t3 (2 months post-intervention), t4 (3 months post-intervention)
Awards & highlights
No Placebo-Only Group

Summary

This trial examines if the COPE intervention can help adults in disaster-affected communities with mental health, coping, social support and community resilience.

Who is the study for?
This trial is for adults over 18 who are staff or members of Together Baton Rouge. It's aimed at those involved in or affected by recent disasters, focusing on improving mental health and resilience.
What is being tested?
The COPE intervention, which includes three sessions designed to enhance mental well-being, coping skills, social support, and community resilience after a disaster. Its effectiveness will be compared with standard house meetings.
What are the potential side effects?
Since COPE is a psychosocial intervention rather than a medical treatment, it may not have typical 'side effects,' but participants might experience emotional discomfort discussing stressful experiences.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~t1 (pre-intervention), t2 (1 month post-intervention), t3 (2 months post-intervention), t4 (3 months post-intervention)
This trial's timeline: 3 weeks for screening, Varies for treatment, and t1 (pre-intervention), t2 (1 month post-intervention), t3 (2 months post-intervention), t4 (3 months post-intervention) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in anxiety symptoms from baseline
Change in community resilience from baseline
Change in coping from baseline
+4 more
Secondary study objectives
Intervention acceptibility
Intervention appropriateness
Intervention feasibility
Other study objectives
Focus groups
Intervention fidelity
Interviews

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: COPE InterventionExperimental Treatment1 Intervention
Is a three session brief group psychoeducational intervention. Session 1 is 4 hours, Session 2 and 3 are 1.5 hours. It is delivered in groups of 8-15 people with sessions spaced 1 month apart.
Group II: House Meeting ControlActive Control1 Intervention
Is a 1.5 hour group meeting delivered in groups of 8-15 people spaced 1 month apart.

Find a Location

Who is running the clinical trial?

Louisiana State University and A&M CollegeLead Sponsor
10 Previous Clinical Trials
783 Total Patients Enrolled
National Academies of Sciences, Engineering and MedicineUNKNOWN
University of Illinois at Urbana-ChampaignOTHER
199 Previous Clinical Trials
40,165 Total Patients Enrolled
Jennifer L Scott, PhD, LCSWPrincipal InvestigatorLouisiana State University Health Sciences Center in New Orleans
~58 spots leftby Jun 2025